Oral Oncology
Volume 46, Issue 4 , Pages 317-322 , April 2010

MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines

  • Zhi-wei Yu
    • ,
  • Lai-ping Zhong

      Affiliations

    • Corresponding Author InformationCorresponding authors. Address: Department of Oral and Maxillofacial Surgery, Ninth People’s Hospital, School of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, No. 639 Zhizaoju Road, Shanghai 200011, China. Tel.: +86 21 23271699 5154; fax: +86 21 63136856 (L.-p. Zhong); tel.: +86 21 23271699 5161; fax: +86 21 63136856 (C.-p. Zhang).
    • ,
  • Tong Ji
    • ,
  • Ping Zhang
    • ,
  • Wan-tao Chen
    • ,
  • Chen-ping Zhang

      Affiliations

    • Corresponding Author InformationCorresponding authors. Address: Department of Oral and Maxillofacial Surgery, Ninth People’s Hospital, School of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, No. 639 Zhizaoju Road, Shanghai 200011, China. Tel.: +86 21 23271699 5154; fax: +86 21 63136856 (L.-p. Zhong); tel.: +86 21 23271699 5161; fax: +86 21 63136856 (C.-p. Zhang).

Received 4 January 2010 ,Revised 31 January 2010 ,Accepted 1 February 2010.

References 

  1. Dai Z, Huang Y, Sadee W. Growth factor signaling and resistance to cancer chemotherapy. Curr Top Med Chem. 2004;4:1347–1356
  2. Huang Y, Anderle P, Bussey KJ, Barbacioru C, Shankavaram U, Dai Z, et al. Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res. 2004;64:4294–4301
  3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297
  4. Sontheimer EJ. Assembly and function of RNA silencing complexes. Nat Rev Mol Cell Biol. 2005;6:127–138
  5. Filipowicz W, Jaskiewicz L, Kolb FA, Pillai RS. Post-transcriptional gene silencing by siRNAs and miRNAs. Curr Opin Struct Biol. 2005;15:331–341
  6. Bentwich I. A postulated role for microRNA in cellular differentiation. FASEB J. 2005;19:875–879
  7. Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development. 2005;132:4653–4662
  8. Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer. 2007;6:60
  9. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–866
  10. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 2004;101:2999–3004
  11. Herzog CE, Holmes KA, Tuschong LM, Ganapathi R, Zwelling LA. Absence of topoisomerase II beta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase II alpha. Cancer Res. 1998;58:5298–5300
  12. Azarova AM, Lyu YL, Lin CP, Tsai YC, Lau JYN, Wang JC. Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. PNAS. 2007;104:11014–11019
  13. Nitiss JL. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer. 2009;9:338–350
  14. Zhang P, Zhang Z, Zhou X, Qiu W, Chen F, Chen W. Identification of genes associated with cisplatin resistance in human oral squamous carcinoma cell line. BMC Cancer. 2006;6:224
  15. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology. 2006;130:2113–2129
  16. Blower PE, Chung JH, Verducci JS, Lin S, Park JK, Dai Z, et al. MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther. 2008;7:1–9
  17. Moriyama T, Ohuchida K, Mizumoto K, Yu J, Sato N, Nabae T, et al. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther. 2009;8:1067–1074
  18. Yang H, Kong W, He L, Zhao JJ, O’Donnell JD, Wang J, et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 2008;68:425–433
  19. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 2007;25:387–392
  20. Huang S, He X, Ding J, Liang L, Zhao Y, Zhang Z, et al. Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer. 2008;123:972–978
  21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods. 2001;25:402–408

PII: S1368-8375(10)00035-7

doi: 10.1016/j.oraloncology.2010.02.002

Oral Oncology
Volume 46, Issue 4 , Pages 317-322 , April 2010

Article Tools

* Image Usage & Resolution